Titan: The brokerage maintains a ‘neutral’ call on the stock with a target at Rs 1,170 per share. It added that the company’s recovery is likely to lag heightened expectations.
The brokerage maintains an ‘outperform’ call on the stock with a target at Rs 5,550 per share. It added that the company’s Q2 will be better than expected with strength driven by US sales.
Dr Reddy’s: The brokerage maintains an ‘outperform’ call on the stock with a target at Rs 5,550 per share. It added that the company’s Q2 will be better than expected with strength driven by US sales.
The brokerage maintains a ‘buy’ call on the stock with a target at Rs 1,400 per share. It added that the company shows clear signs of execution in H2.
L&T: The brokerage maintains a ‘buy’ call on the stock with a target at Rs 1,400 per share. It added that the company shows clear signs of execution in H2.
The brokerage maintains a ‘buy’ call on the stock with a target at Rs 700 per share. It added that the company’s asset quality commentary indicates COVID-related stress is manageable.
Axis Bank: The brokerage maintains a ‘buy’ call on the stock with a target at Rs 700 per share. It added that the company’s asset quality commentary indicates COVID-related stress is manageable.
The brokerage says big inflow raises FPI ownership. As of now, retail ownership is at a 12-quarter high and healthcare, staples weighting increased for FPIs and DMFs.
Market Strategy: The brokerage says big inflow raises FPI ownership. As of now, retail ownership is at a 12-quarter high and healthcare, staples weighting increased for FPIs and DMFs
Average Rating